Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)

China · Delayed Price · Currency is CNY

17.96

+1.63 (9.98%)

Aug 4, 2026, 3:00 PM CST

SHA:603990 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	299.83	301.48	464.07	618.14	305.51	353.85
Revenue Growth	-27.93%	-35.04%	-24.93%	102.33%	-13.66%	14.86%
Gross Profit	178.48	181.98	51.17	112.82	215.46	246.99
Operating Income	14.24	17.29	-214.55	-218.91	33.3	43.83
Net Income	19.41	39.16	-279.47	-269.42	33.56	41.95
Earnings Per Share	0.06	0.13	-0.92	-0.88	0.12	0.15
EPS Growth	-	-	-	-	-21.98%	8.31%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Software and Information Technology Services	242.32
Medical Service Income	58.07
Total Solution	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	538.43	293.97	159.44	638.29	971.41	641.27
Total Debt	262.22	275.98	420.45	1,711	163.18	80.63
Net Cash (Debt)	276.21	17.99	-261.01	-1,072	808.23	560.64
Net Cash Growth	73623.97%	-	-	-	44.16%	-27.35%
Net Cash Per Share	0.85	0.06	-0.86	-3.50	2.89	2.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	75.95	65.41	-11.39	-316.65	50.51	36.04
Capital Expenditures	-42.77	-68.58	-252.29	-599.84	-24.58	-40.99
Free Cash Flow	33.18	-3.17	-263.69	-916.49	25.93	-4.95
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	59.53%	60.36%	11.03%	18.25%	70.52%	69.80%
Operating Margin	4.75%	5.73%	-46.23%	-35.41%	10.90%	12.39%
Pretax Margin	7.98%	15.06%	-54.68%	-42.38%	14.26%	14.51%
Profit Margin	6.47%	12.99%	-60.22%	-43.59%	10.98%	11.86%
FCF Margin	11.07%	-1.05%	-56.82%	-148.27%	8.49%	-1.40%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	272.30	117.26	-	-	120.50	86.63
Forward PE	-	12.33	12.33	73.83	29.41	25.32
P/FCF Ratio	148.45	-	-	-	155.93	-
PS Ratio	16.43	15.23	6.72	6.34	13.24	10.27